摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

S-叔丁基-L-半胱氨酸叔丁酯 | 45157-84-4

中文名称
S-叔丁基-L-半胱氨酸叔丁酯
中文别名
——
英文名称
S-tert.-Butyl-L-cystein-tert.-butylester
英文别名
tert-butyl (2R)-2-amino-3-(tert-butylsulfanyl)propanoate;tert-butyl (2R)-2-amino-3-tert-butylsulfanylpropanoate
S-叔丁基-L-半胱氨酸叔丁酯化学式
CAS
45157-84-4
化学式
C11H23NO2S
mdl
——
分子量
233.375
InChiKey
LYGGEHGWPZTHJD-QMMMGPOBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    15
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.91
  • 拓扑面积:
    77.6
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • 丹参素与H2S/NO供体结合物及其制备方法和在制药中的应用
    申请人:复旦大学
    公开号:CN111484413A
    公开(公告)日:2020-08-04
    本发明属化学制药领域,涉及中草药丹参中有效成分丹参素与H 2 S/NO供体的结合物及其制备方法和在制药中的应用,尤其是在制备防治心脑血管和炎症相关疾病药物中的用途。本发明通过体外氧化应激损伤和炎症模型实验,结果显示所述的结合物能显著抑制H 2 O 2 诱导的SH‑SY5Y细胞氧化应激损伤,对损伤细胞具有明显的保护作用;能显著抑制内毒素(LPS)诱导的小鼠腹腔巨噬细胞分泌炎性介质,减少炎症诱导的一氧化氮和炎性细胞因子的释放;体内活性实验结果显示,所述的结合物对LPS诱导的小鼠腹膜炎能改善小鼠的凝血时间,明显抑制小鼠腹腔的炎性细胞因子的释放,结果表明所述化合物可用于制备防治心脑血管疾病和炎症性疾病的药物。
  • Stereoselective synthesis of novel N-(α-l-arabinofuranos-1-yl)-l-amino acids
    作者:Ming Zhao、Yuji Wang、Caixia Huo、Chunyu Li、Xiaoyi Zhang、Li Peng、Shiqi Peng
    DOI:10.1016/j.tetasy.2009.01.014
    日期:2009.2
    were converted to α- and β-anomers of N-(2,3,5-tri-O-acetyl-l-arabinofuranosyl)-N-(2-nitrobenzenesulfonyl)-l-amino acids, 3a–f-α and 3a–f-β, in 87–92% yields. While in the presence of NaOCH3, 3a–f-α and 3a–f-β were converted to α- and β-anomers of N-(l-arabinofuranosyl)-N-(2-nitrobenzenesulfonyl)-l-amino acids, 4a–f-α and 4a–f-β, in 90–96% yields. Treating 4a–f-α and 4a–f-β with N-ethyldiisopropylamine
    解毒中,N-糖基-1-氨基酸的α-端基异构体比其β-端基异构体更有效。这里报道了用于立体选择性地制备N-(α-1-阿拉伯糖-1-基)-1-氨基酸的六步反应路线。用乙酸酐乙酸处理1-阿拉伯糖,得到90%产率的1,2,3,5-四-O-乙酰基-1-阿拉伯呋喃糖。除去1-乙酰基后,将由此形成的2,3,5-三-O-乙酰基-1-阿拉伯呋喃糖和N-(2-硝基苯基磺酰基)-1-氨基酸叔丁基酯用三苯基膦处理以进行Mitsunobu脱并形成2,3,5-三-O-乙酰基-1-阿拉伯呋喃糖基-1- [ N-(2-硝基苯基磺酰基)]氨基酸叔丁基酯2a-f,其α-与β-端基异构体的比例为8/1至9/1。色谱分离提供差向异构纯2a–f-α和2a–f-β。在存在CF 3 CO 2 H的情况下,2a–f-α和2a–f-β转化为N-(2,3,5-三-O-乙酰基-1-阿拉伯呋喃糖基)的α-和β-异头物。- ñ - (2
  • Acid-Labile Protecting Groups for the Synthesis of Lipidated Peptides
    作者:Dieter Kadereit、Patrick Deck、Ines Heinemann、Herbert Waldmann
    DOI:10.1002/1521-3765(20010316)7:6<1184::aid-chem1184>3.0.co;2-5
    日期:2001.3.16
    Lipidated peptides and their neolipoprotein derivatives are efficient tools for the investigation of biological processes in molecular detail. These compounds are often acid- and base-labile, and their synthesis requires the use of a combination of blocking groups that can be removed under very mild conditions. In this article we demonstrate that the Boc urethane and different trityl-type protecting groups
    脂质肽及其新脂蛋白衍生物是用于详细研究分子生物学过程的有效工具。这些化合物通常对酸和碱不稳定,并且它们的合成需要使用可以在非常温和的条件下除去的保护基团的组合。在本文中,我们证明了Boc氨基甲酸酯和不同的三苯甲基型保护基可以在足够温和以适应脂肽合成需求的酸性条件下选择性裂解。因此,在二甲基吡啶存在的情况下,Boc基团被TMS三氟甲磺酸酯裂解,在三乙基硅烷作为阳离子清除剂的情况下,在二氯甲烷中用1%TFA除去甲基三苯甲基(Mtt)和甲氧基三苯甲基(Mmt)基团。
  • Therapeutic effect and mechanism study of L-cysteine derivative 5P39 on LPS-induced acute lung injury in mice
    作者:Yanting He、Yalei Zhao、Yuchen Feng、Anqi Ren、Yunyi Zhang、Yang Wang、Hong Li
    DOI:10.1016/j.ejphar.2019.172893
    日期:2020.2
    Organosulfur compounds, such as L-cysteine, allicin and other sulfur-containing organic compounds in Allium species, have been proposed to possess many important physiological and pharmacological functions. A novel L-cysteine derivative, t-Butyl S-allylthio-L-cysteinate (5P39), was designed and synthesized by combining L-cysteine derivative and allicin pharmacophore through a disulfide bond. This study aimed to explore the effects and mechanisms of 5P39 on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice. At the experimental concentration (5, 10 and 20 mu M), 5P39 suppressed the excessive secretion of nitric oxide (NO) and interleukin-6 (IL-6) in mice peritoneal macrophages stimulated by LPS. A mouse model of ALI was established by tracheal instillation of LPS for 2 h before 5P39 (30 and 60 mg/kg) administration. The results showed that 5P39 treatment down-regulated the wet/dry weight ratio (W/D ratio) of lungs and reduced the protein concentration, the number of total cells as well as the myeloperoxidase (MPO) activity in bronchoalveolar lavage fluid (BALF). 5P39 administration improved the histopathological changes of lungs in ALI mice with the decreased levels of pro-inflammatory cytokines in BALF. The inhibitory effects of 5P39 on the toll-like receptor 4 (TLR4) expression and macrophages accumulation in lung tissues were observed by immunohistochemistry. Additionally, 5P39 significantly attenuated the LPS-activated high expression of key proteins in TLR4/MyD88 signaling pathway. Taken together, the present study showed that 5P39 effectively alleviate the severity of ALI, and its mechanism might relate to the inhibition of LPS-activated TLR4/MyD88 signaling pathway, demonstrating a promising potential for further development into an anti-inflammatory drug candidate.
  • <b>The Tertiary Butyl Group as a Blocking Agent for Hydroxyl, Sulfhydryl and Amido Functions in Peptide Synthesis</b>
    作者:Francis M. Callahan、George W. Anderson、Rolf. Paul、Joan E. Zimmerman
    DOI:10.1021/ja00885a020
    日期:1963.1
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸